Market Tracker

04/17 6:05pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

8.41
Data as of Apr 17
 +0.16 / +1.94%
Today’s Change
7.33
Today|||52-Week Range
10.21
-0.36%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close8.25
Today’s open8.25
Day’s range8.11 - 8.48
Volume4,166,992
Average volume (3 months)3,394,900
Market cap$1.3B
Dividend yield7.13%
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+17.00%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio4.9
Price/Sales2.66
Price/Book10.14

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+1.23+1.96%
AUXLAuxilium Pharmaceuti...-0.49-1.85%
ARNAArena Pharmaceutical...-0.12-1.90%
INSYInsys Therapeutics I...+1.88+5.11%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)$0.47
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts